2HE:F:F-Healthequity Inc (EUR)

COMMON STOCK | Health Information Services |

Last Closing

USD 78

Change

0.00 (0.00)%

Market Cap

USD 6.90B

Volume

45.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-02 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
L0T:F GE HEALTHCARE TECH.INC.

N/A

USD 37.77B
4YC:F M3 INC.

N/A

USD 6.89B
6HL0:F R1 RCM Inc

N/A

USD 5.57B
9EH:F Evolent Health Inc

N/A

USD 2.44B
OC9:F Omnicell Inc

N/A

USD 2.04B
1KJ:F 10X GENOMICS DL -00001

N/A

USD 1.73B
6JM:F JMDC INC.

N/A

USD 1.69B
1XZ:F Ping An Healthcare and Technol..

N/A

USD 1.55B
4LL:F Teladoc Inc

N/A

USD 1.50B
19P:F Phreesia Inc

N/A

USD 0.98B

ETFs Containing 2HE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 31.09% 83% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.09% 83% B 82% B
Trailing 12 Months  
Capital Gain 25.81% 77% C+ 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.81% 77% C+ 71% C-
Trailing 5 Years  
Capital Gain 48.57% 82% B 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.57% 82% B 72% C
Average Annual (5 Year Horizon)  
Capital Gain 10.08% 79% B- 68% D+
Dividend Return 10.08% 77% C+ 61% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 21.96% 70% C- 60% D-
Risk Adjusted Return 45.90% 85% B 65% D
Market Capitalization 6.90B 98% N/A 82% B

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.